Endometriosis Drugs Market by Product and Geography - Forecast and Analysis 2021-2025

Executive Summary

• Market overview

Market Landscape

• Market ecosystem

Market Sizing

• Market definition
• Market segment analysis
• Market size 2020
• Market outlook: Forecast for 2020-2025

Five Forces Analysis

• Five forces summary
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

Market Segmentation by Product

• Market segments
• Comparison by Product
• Hormone therapy - Market size and forecast 2020-2025
• Analgesics - Market size and forecast 2020-2025
• Market opportunity by Product

Customer Landscape

• Overview

Geographic Landscape

• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2020-2025
• Europe - Market size and forecast 2020-2025
• Asia - Market size and forecast 2020-2025
• Rest of World (ROW) - Market size and forecast 2020-2025
• US - Market size and forecast 2020-2025
• UK - Market size and forecast 2020-2025
• Japan - Market size and forecast 2020-2025
• Germany - Market size and forecast 2020-2025
• Canada - Market size and forecast 2020-2025
• Market opportunity by geography

Drivers, Challenges, and Trends

• Market drivers
• Market challenges
• Impact of drivers and challenges
• Market trends

Vendor Landscape

• Overview
• Vendor landscape
• Landscape disruption

Vendor Analysis

• Vendors covered
• Market positioning of vendors
• AbbVie Inc.
• AstraZeneca Plc
• Bayer AG
• Debiopharm International SA
• Gedeon Richter Plc
• Mayne Pharma Group Ltd.
• Merck and Co. Inc.
• Pfizer Inc.
• Takeda Pharmaceutical Co. Ltd.
• Teva Pharmaceutical Industries Ltd.

Appendix

• Scope of the report
• Inclusions and exclusions checklist
• Currency conversion rates for US$
• Research methodology
• List of abbreviations